tokens: The mechanism of CS protection does not appear to be dependent on the inhibition of chemical bioactivation to a toxic reactive intermediate ( in light of the protection observed against galactosamine hepatotoxicity ). However , based on the data presented , we can not exclude the possibility that CS administration inhibits chemical bioactivation .